IL90514A - A fusion gene that contains a gene for multidrug resistance that is fused to a gene for adenine diamines - Google Patents

A fusion gene that contains a gene for multidrug resistance that is fused to a gene for adenine diamines

Info

Publication number
IL90514A
IL90514A IL9051489A IL9051489A IL90514A IL 90514 A IL90514 A IL 90514A IL 9051489 A IL9051489 A IL 9051489A IL 9051489 A IL9051489 A IL 9051489A IL 90514 A IL90514 A IL 90514A
Authority
IL
Israel
Prior art keywords
gene
ada
fusion
cells
fusion gene
Prior art date
Application number
IL9051489A
Other languages
English (en)
Hebrew (he)
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Publication of IL90514A publication Critical patent/IL90514A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL9051489A 1988-06-03 1989-06-02 A fusion gene that contains a gene for multidrug resistance that is fused to a gene for adenine diamines IL90514A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20278388A 1988-06-03 1988-06-03

Publications (1)

Publication Number Publication Date
IL90514A true IL90514A (en) 1995-10-31

Family

ID=22751243

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9051489A IL90514A (en) 1988-06-03 1989-06-02 A fusion gene that contains a gene for multidrug resistance that is fused to a gene for adenine diamines

Country Status (8)

Country Link
EP (1) EP0420911B1 (fr)
JP (1) JP2949440B2 (fr)
AT (1) ATE142269T1 (fr)
AU (1) AU634162B2 (fr)
CA (1) CA1339654C (fr)
DE (1) DE68927104T2 (fr)
IL (1) IL90514A (fr)
WO (1) WO1989012109A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990004632A1 (fr) * 1988-10-21 1990-05-03 The United States Of America, Represented By The Secretary, United States Department Of Commerce Animaux transgeniques pour tester la resistance a de multiples medicaments
US5756353A (en) * 1991-12-17 1998-05-26 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol-and liposome-based delivery
US6627615B1 (en) 1991-12-17 2003-09-30 The Regents Of The University Of California Methods and compositions for in vivo gene therapy
US5858784A (en) * 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
IL105914A0 (en) * 1992-06-04 1993-10-20 Univ California Methods and compositions for in vivo gene therapy
US6806084B1 (en) 1992-06-04 2004-10-19 The Regents Of The University Of California Methods for compositions for in vivo gene delivery
DE4238778C2 (de) * 1992-11-12 1995-11-02 Max Delbrueck Centrum Vektor zur Expression von therapeutisch relevanten Genen
US5968735A (en) * 1992-11-12 1999-10-19 Max Delbruck-Centrum Fur Molekular Medizin Berlin Vector for the expression of therapy-relevant genes
US6344445B1 (en) 1995-10-19 2002-02-05 Cantab Pharmaceutical Research Limited Herpes virus vectors and their uses
GB9622500D0 (en) * 1996-10-29 1997-01-08 Oxford Biomedica Ltd Therapeutic gene
GB2333527B (en) * 1996-10-29 2001-05-02 Oxford Biomedica Ltd Therapeutic gene
US6924123B2 (en) 1996-10-29 2005-08-02 Oxford Biomedica (Uk) Limited Lentiviral LTR-deleted vector
EP2895598B1 (fr) 2012-09-11 2019-02-27 Corning Incorporated Cellules cryoconservées consommables surexprimant transitoirement un ou des gènes codant pour une ou des protéines transporteurs de médicament et/ou une ou des enzymes de métabolisation d'un médicament

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095361B1 (fr) * 1982-05-25 1989-07-26 Eli Lilly And Company Vecteurs de clonage pour l'expression de protéine exogène
DE3715033A1 (de) * 1987-05-06 1988-11-17 Hoechst Ag Verfahren zur isolierung von fusionsproteinen
WO1990004632A1 (fr) * 1988-10-21 1990-05-03 The United States Of America, Represented By The Secretary, United States Department Of Commerce Animaux transgeniques pour tester la resistance a de multiples medicaments
AU636630B2 (en) * 1989-06-23 1993-05-06 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Efficient method for identifiable expression of non-selectable genes

Also Published As

Publication number Publication date
JPH03505818A (ja) 1991-12-19
EP0420911A4 (en) 1991-11-13
DE68927104D1 (de) 1996-10-10
EP0420911B1 (fr) 1996-09-04
WO1989012109A1 (fr) 1989-12-14
AU634162B2 (en) 1993-02-18
DE68927104T2 (de) 1997-03-06
EP0420911A1 (fr) 1991-04-10
JP2949440B2 (ja) 1999-09-13
AU3778889A (en) 1990-01-05
ATE142269T1 (de) 1996-09-15
CA1339654C (fr) 1998-02-03

Similar Documents

Publication Publication Date Title
US5166059A (en) Gene therapy using gene fusions for genetic or acquired disorders
CN101410525B (zh) 生产多肽的细胞
Shalloway et al. Overexpression of the c-src protein does not induce transformation of NIH 3T3 cells.
KR970002915B1 (ko) 제ⅷ인자 활성을 가지는 신규한 단백질 : 유전공학-제조 세포를 사용하는 그의 제조방법 및 그것을 함유하는 의약 조성물
AU634162B2 (en) Gene therapy using gene fusions for genetic or acquired disorders
US6743622B2 (en) Homologous recombination antibody expression system for murine cells
Ibanez et al. Structural and functional domains of the myb oncogene: requirements for nuclear transport, myeloid transformation, and colony formation
Schwartz et al. A dominant positive and negative selectable gene for use in mammalian cells.
ES2213925T5 (es) Seleccion entre positivos y negativos en el caso de la recombinacion homologa.
Ichihara et al. Impaired interleukin‐3 (IL‐3) response of the A/J mouse is caused by a branch point deletion in the IL‐3 receptor alpha subunit gene.
US5238820A (en) Multiply-amplifiable vectors for high level expression of exogenuos DNA
US4828987A (en) Avian retrovirus-bovine growth hormone DNA
Moncman et al. Segregated assembly of muscle myosin expressed in nonmuscle cells.
JPH06507550A (ja) ゲノム性要素を使用する遺伝子の操作および発現
Banga et al. Complementation of V (D) J recombination defect and X-ray sensitivity of scid mouse cells by human chromosome 8
AU609128B2 (en) Leukaemia-inhibitory factor
EP0247145B1 (fr) Vecteurs amplifiables par multiplication pour expression d'adn hexogene en grande quantite
Bartels et al. Synthesis of a wheat storage protein subunit in Escherichia coli using novel expression vectors
Yee et al. Epitope insertion into the human hypoxanthine phosphoribosyltransferase protein and detection of the mutant protein by an anti-peptide antibody
Chang et al. Expression of a human cDNA encoding a protein containing GAR synthetase, AIR synthetase, and GAR transformylase corrects the defects in mutant Chinese hamster ovary cells lacking these activities
CN109790214B (zh) 用于选择产生多肽的细胞的改进方法
Oda et al. Translation initiation sites and relative activity of large and small forms of human choline acetyltransferase
CN113930448A (zh) 一种利用含有硒代半胱氨酸的gpi锚定蛋白表达系统及高表达重组蛋白的细胞
MXPA00003804A (es) Seleccion positiva- negativa durante la recombinacion homologa

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees